Testing effectiveness (Phase 2)Study completedNCT02239224
What this trial is testing
Safety, Tolerability, Pharmacokinetics, and Biological Activity of ATYR1940 in Adult Participants With Muscular Dystrophy
Who this might be right for
Facioscapulohumeral Muscular Dystrophy (FSHD)
aTyr Pharma, Inc. 20